Zheng-Zheng Yu
Overview
Explore the profile of Zheng-Zheng Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cao X, Peng J, Qiu Y, Zhu W, Cao J, Zou H, et al.
Chin Med
. 2025 Mar;
20(1):32.
PMID: 40050970
Background: Fructus Viticis Total Flavonoids (FVTF) is a novel candidate preparation that possesses anticancer activity. However, the role and mechanism of FVTF-inhibiting human hepatocellular carcinoma (HCC) cell stem properties is...
2.
Tang J, Peng Y, Zhu W, Qiu J, Huang W, Yi H, et al.
Int J Biol Sci
. 2025 Feb;
21(3):893-909.
PMID: 39897046
Radioresistance poses a major challenge in nasopharyngeal carcinoma (NPC) treatment. However, the underlying mechanism of NPC radioresistance remains poorly understood, and the promising radiosensitizer for NPC radiotherapy is also lacked....
3.
Xiao D, Zeng T, Zhu W, Yu Z, Huang W, Yi H, et al.
Cancer Immunol Res
. 2023 Aug;
11(10):1367-1383.
PMID: 37566399
The deregulation of Annexin A1 (ANXA1), a regulator of inflammation and immunity, leads to cancer growth and metastasis. However, whether ANXA1 is involved in cancer immunosuppression is still unclear. Here,...
4.
Yu Z, Liu Y, Zhu W, Xiao D, Huang W, Lu S, et al.
J Immunother Cancer
. 2023 Mar;
11(3).
PMID: 37001908
Background: Immune checkpoint inhibitors (ICIs) therapy targeting programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) shows promising clinical benefits. However, the relatively low response rate highlights the need...
5.
Feng J, Lu S, Xiao T, Huang W, Yi H, Zhu W, et al.
Cancer Res
. 2020 Aug;
80(20):4386-4398.
PMID: 32737118
Overexpression of ANXA1 and EphA2 has been linked to various cancers and both proteins have attracted considerable attention for the development of new anticancer drugs. Here we report that ANXA1...
6.
Li Q, Xiao T, Zhu W, Yu Z, Huang X, Yi H, et al.
Cell Death Dis
. 2020 May;
11(5):322.
PMID: 32376822
HDAC7 plays a crucial role in cancers, and is the main drug target of several HDAC inhibitors. However, the role and mechanism of HDAC7 in nasopharyngeal carcinoma (NPC) are still...
7.
Yu Z, Chen J, Shou P, Feng L
Int J Clin Exp Med
. 2014 Oct;
7(9):2754-62.
PMID: 25356136
Male infertility is a serious global medical and social issue demanding more specific and effective treatments. In this study, we generated a male infertility rat model using adenine induction to...